Multiple Sclerosis News Today Daily Digest

Posted by & filed under MS News.

Worth reading, the Ocrelizumab (Ocrevus) story, plus second and third items.  But a warning to all, not all the comments are positive.

Multiple Sclerosis News Today

The Web’s Daily Resource for Multiple Sclerosis News

In the 05/13/2019 edition:

Excerpts:MS News that Caught My Eye Last Week: Lemtrada Satisfaction, Limiting Tysabri’s PML Risk, MS and Pregnancy, Infusions Vs. Pills#AANAM – RRMS Patients Switching to Lemtrada Report Greater Satisfaction with Treatment and Improvements in Quality of Life I’m a self-proclaimed secondary progressive, rather than a remitting, multiple sclerosis (MS) person. But a year after round two of Lemtrada (alemtuzumab), I can agree with this report. Several of my symptoms are better, most notably my […]The post MS News that Caught My Eye Last Week: Lemtrada Satisfaction, Limiting Tysabri’s PML Risk, MS and Pregnancy, Infusions Vs. Pills appeared first on Multiple Sclerosis News Today.
Read on »

Ocrevus Approved in UK as First NHS Treatment for PPMSAfter first rejecting it due to cost-effectiveness concerns, the National Institute for Health and Care Excellence (NICE) has now approved the use of Ocrevus (ocrelizumab) for people in the U.K. with early, inflammatory primary progressive multiple sclerosis (PPMS). This means that PPMS patients living in the U.K. will now have access to Ocrevus treatment through the […]The post Ocrevus Approved in UK as First NHS Treatment for PPMS appeared first on Multiple Sclerosis News Today.
Read on »

#AANAM – Ocrevus Effective in RRMS Patients with Poor Responses to Other DMTs, Early Trial Data SuggestEarly, one-year data from the Phase 3 CHORDS study show that Ocrevus effectively prevents relapses and disease progression in relapsing-remitting multiple sclerosis (RRMS) patients who have had poor responses to other disease-modifying therapies. These interim results were presented at the 2019 annual meeting of the American Academy of Neurology (AAN) in the presentation, “One-year interim analysis results of the […]The post #AANAM – Ocrevus Effective in RRMS Patients with Poor Responses to Other DMTs, Early Trial Data Suggest appeared first on Multiple Sclerosis News Today.
Read on »

#AANAM – Aubagio at Higher Dose Shows Long-term Efficacy in Variety of Patients, Trial Data ShowAubagio taken as 14 milligram (mg) tablet once daily significantly reduces the risk of relapse in people with relapsing multiple sclerosis (MS) over time irrespective of their prior treatment history, a pooled analysis of Phase 2 and Phase 3 trial results show. The findings were presented at the 2019 American Academy of Neurology (AAN) Annual Meeting, […]The post #AANAM – Aubagio at Higher Dose Shows Long-term Efficacy in Variety of Patients, Trial Data Show appeared first on Multiple Sclerosis News Today.
Read on »

I Survived a Marathon Comedy FestivalExactly one year ago on this day of writing, I was down and out. This year, I’m not exactly fighting fit, but the same set of circumstances has pushed me the distance. But it didn’t floor me. OK, OK, I’ll stop with the pugilistic metaphors — it’s not exactly knocking you out! Last year, I […]The post I Survived a Marathon Comedy Festival appeared first on Multiple Sclerosis News Today.
Read on »

#AANAM – Interferon Beta Exposure Does Not Seem to Increase Risk of Pregnancy Complications, Study SuggestsExposure to interferon beta does not seem to increase the risk of complications during pregnancy in women with multiple sclerosis (MS), new research suggests. The data were presented in an oral presentation, “Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Preg study conducted in Finland and […]The post #AANAM – Interferon Beta Exposure Does Not Seem to Increase Risk of Pregnancy Complications, Study Suggests appeared first on Multiple Sclerosis News Today.
Read on »


General Meeting 13th June 2019

Posted by & filed under Centre News.

Notice of General Meeting

Notice is hereby given that a General Meeting (Meeting) of The M.S. Therapy Centre (Oxford) Ltd (Company) will be held at 37e, Innovation Drive, Milton Park, Abingdon, OX14 4RT on June 13th2019 at noon.

You will be asked to consider and vote on the resolution below. The resolution will be proposed as a special resolution.

SPECIAL RESOLUTION

THAT the articles of association in the form tabled at the meeting be and are hereby adopted as the articles of association of the Company in substitution for and to the exclusion of all other articles of association.

A copy of the Articles is attached to this notice.

By order of the Board

Andrew John Gower

Director

Registered Office

37e, Innovation Drive

Milton Park

Abingdon

OX14 4RT

Registered number: 2318549

May 13th2019

Notes to the Notice of General Meeting

If any member wishes to appoint a proxy, or wishes to receive an electronic copy of the articles before the meeting, please contact the chairman at andrewgower8@gmail.com.


We both now have hope – MS sisters

Posted by & filed under MS News.

Sisters Zoe Bowman and Vikki Langford were both diagnosed with multiple sclerosis within weeks of each other.

But while Vikki has been able to get treatment for her form of the condition, Zoe has not.

That is because Zoe has the primary progressive form of the disease for which there has been no treatment available on the NHS. Until now.

“MS doesn’t stop me, it just makes me do things a little differently”

Posted by & filed under MS News.

Source MS Trust: When Emma was diagnosed with MS aged 27, she admits it was a ‘devastating’ time. But, 10 years later, she is determined to focus on the positives.  In this blog, Emma writes about her MS diagnosis, life as a farmer, and why she won’t let MS beat her. 

I always thought I was fairly indestructible. Growing up on a busy dairy farm with two brothers, meant that you had to be. This was until I awoke one morning with a numb hand.  I was 27 and working in London at the time. I just thought that I had slept on it funny. 

Three weeks later, I was admitted to the hospital after my left-hand side had completely shut down. I underwent a comprehensive set of tests and scans, MRIs and a lumbar puncture. My diagnosis was conclusive. Three telltale scars on my brain and MS cells in my spine. I couldn’t believe it. My family and I knew very little about the disease but the mor

Stem Cells in Mouse Hair Seen to Aid Growth of ‘Dense’ Myelin Sheaths Around Nerve Cells, Study Reports

Posted by & filed under MS News.

Source Multiple Sclerosis News Today: A subset of stem cells in hair follicles, called melanocytes, appear to do more than just give rise to mature melanocytes, cells that help to determine hair colour. Those melanocyte stem cells, or McSCs, that carry the CD34 protein were found in hair follicles from mice to differentiate into glial cells and support myelin production, a study reports.

Whether these McSCs also exist in human hair, and so might potentially treat demyelinating diseases like multiple sclerosis (MS) or traumatic nerve injury, will be the focus of further research.  Read on. 

Make your own hanging basket

Posted by & filed under Events.

Hello to the Milton Park community,Summer is just around the corner! And to help get everyone’s garden’s in tip top shape, the Milton Park and Nurture Landscape teams have joined forces to bring you a “Make Your Own Hanging Basket” event.The event is FREE but we would greatly appreciate it if you could donate up to £10 to our two onsite charities – DAMASCUS Youth Project and MS Therapy Centre. There are three one hour slots available:  11am – 12pm12pm – 1pm1pm – 2pm SELECT YOUR TIME SLOT NOW
When – Friday 10th MayWhere – Park Drive Central (Wandering Feast site)
Please note, slots will be allocated on a first come, first served basis. If you have any questions, please contact Nancy Apperley on napperley@mepc.com.See you there!The Milton Park Team